Respiratory syncytial virus (RSV) infections occurred more frequently than human metapneumovirus (hMPV) infections in adults with chronic underlying health conditions. The odds of RSV test positivity ...
Hosted on MSN
Can adults get RSV? What to know about your risk
Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...
"This study includes CDC’s first comprehensive estimates of RSV disease burden in U.S. adults, including hospitalizations and in-hospital deaths. It demonstrates that RSV caused a substantial burden ...
New research highlights the effectiveness of RSV preF vaccines in preventing severe respiratory infections in older adults. RSV is increasingly recognized as a substantial contributor to morbidity and ...
Using a latent class analysis model, researchers demonstrated that standard test positivity rates overestimate the true prevalence of RSV due to testing inaccuracies. The hospitalization rate for ...
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults. For months after discharge, adults young and old often live with profound ...
RSV cases and hospitalizations in California are rising this winter season. Infants and older adults face higher risk of severe RSV infection. Vaccination and hygiene help prevent spread. Respiratory ...
A nationwide Danish cohort study reports cardiovascular events up to 1 year after infection, comparable to that observed with influenza. A nationwide Danish cohort study reports cardiovascular events ...
A Danish national registry trial shows the RSVpreF vaccine is highly effective at preventing severe RSV illness and related hospitalizations in older adults, offering real-world support for broader ...
One shot of an RSV vaccine protects adults aged 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons, according to a study published in JAMA by the ...
Researchers found that RSV protein subunit vaccines probably reduce RSV-related hospitalization (vaccine efficacy, 83.3%) and severe RSV illness (vaccine efficacy, 94.1%) in older adults. HealthDay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results